Leukocyte-endothelial cell adhesion: Avenues for therapeutic intervention

British Journal of Pharmacology

Volumn 126, Issue 3, 1999, Pages 537-550

  Panés, Julián ^a   Perry, Michael ^b   Granger, D Neil ^c  

^a HOSPITAL CLÍNIC   (Spain)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

Author keywords

2 integrins; Antisense oligonucleotides; Cytokines; Glucocorticoids; Inflammation; Leukocyte endothelial cell adhesion; Lipid mediators; Nuclear factor kappa B; Selectins

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CELL ADHESION MOLECULE; CYTOKINE; GLUCOCORTICOID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTEGRIN; LIPID; SELECTIN;

CELL ADHESION; ENDOTHELIUM; IMMUNITY; INFLAMMATION; LEUKOCYTE; MEDIATOR; PRIORITY JOURNAL; REVIEW;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL ADHESION; CELL ADHESION MOLECULES; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION; HUMANS; LEUKOCYTES;

EID: 0033019214     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702328     Document Type: Review

References (103)

1. ADCOCK, I.M. (1996). Steroid resistance in asthma. Molecular mechanisms. Am. J. Respir. Crit. Care Med., 154, S58-S61.
2. ADCOCK, I.M., LANE, S.J., BROWN, C.R., LEE, T.H. & BARNES, P.J. (1995). Abnormal glucocorticoid receptor-activator protein 1 interaction in steroid-resistant asthma. J. Exp. Med., 182, 1951-1958.
3. AGRAWAL, S. (1996). Antisense oligonucleotides: towards clinical trials. Trends Biotechnol., 14, 376-387.
4. ANDERSON, D.C., SCHMALSTIEG, F.C., SHEARER, W., BECKER, F.-K., KOHL, S., SMITH, C.W., TOSI, M.F. & SPRINGER, T. (1985). Leukocyte LFA-1, OKMI, p150,95 deficiency syndrome: functional and biosynthetic studies of three kindreds. Fed Proc., 44, 2671-2677.
5. ANGEL, P. & KARIN, M. (1991). The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim. Biophys. Acta., 1072, 129-157.
6. APPLEYARD, C.B., MCCAFFERTY, D.M., TIGLEY, A.W., SWAIN, M.G. & WALLACE, J.L. (1996). Tumour necrosis factor mediation of NSAID-induced gastric damage: role of leukocyte adherence. Am. J. Physiol., 270, G42-G48.
7. ARDITE, E., PANÉS, J., MIRANDA, M., SALAS, A., ELIZALDE, J.I., SANS, M., ARCE, Y., BORDAS, J.M., FERNÁNDEZ-CHECA, J.C. & PIQUÉ, J.M. (1998). Effects of steroid treatment on activation of nuclear factor κB in patients with inflammatory bowel disease. Br. J. Pharmacol., 124, 431-433.
8. ARNDT, H., RUSSELL, J.B., KUROSE, I., KUBES, P. & GRANGER, D.N. (1993). Mediators of leukocyte adhesion in rat mesenteric venules elicited by inhibition of nitric oxide synthesis. Gastroenterology, 105, 675-680.
9. ASAKO, H., KUBES, P., WALLACE, J., GAGINELLA, T., WOLF, R.E. & GRANGER, D.N. (1992). Indomethacin-induced leukocyte adhesion in mesenteric venules: role of lipoxygenase products. Am. J. Physiol., 262, G903-G908.
10. BAEUERLE, P.A. (1998). Pro-inflammatory signaling: last pieces in the NF-kappaB puzzle? Curr. Biol., 8, R19-R22.
11. BAUME, D., KUENTZ, M., PICO, J.L., BEAUJEAN, F., CORDONNIER, C., VERNANT, J.P., HAYAT, M. & BERNARD, A. (1989). Failure of a CD18/anti-LFA1 monoclonal antibody infusion to prevent graft rejection in leukemic patients receiving T-depleted allogeneic bone marrow transplantation. Transplantation, 47, 472-474.
12. BEG, A.A. & BALTIMORE, D. (1996). An essential role for NF-κB in preventing TNF-a-induced cell death. Science, 274, 782-784.
13. BEG, A.A., SHA, W.C., BRONSON, R.T., GHOSH, S. & BALTIMORE, D. (1995). Embryonic lethality and liver degeneration in mice lacking the ReIA component of NF-κB. Nature, 376, 167-170.
14. BENIMETSKAYA, L., LOIKE, J.D., KHALED, Z., LOIKE, G., SILVERSTEIN, S.C., CAO, L., EL KHOURY, J., CAI, T.Q. & STEIN, C.A. (1997). Mac-1 (CD11b/CD18) is an oligodeoxynucleotide-binding protein [see comments]. Nat. Med., 3, 414-420.
15. BENNETT, C.F., CONDON, T.P., GRIMM, S., CHAN, H. & CHIANG, M.Y. (1994). Inhibition of endothelial cell adhesion molecule expression with antisense oligonucleotides. J. Immunol., 152, 3530-3540.
16. BENNETT, C.F., KORNBRUST, D., HENRY, S., STECKER, K., HOWARD, R., COOPER, S., DUTSON, S., HALL, W. & JACOBY, H.I. (1997). An ICAM-1 antisense oligonucleotide prevents and reverses dextran sulfate sodium-induced colitis in mice. J. Pharmacol. Exp. Ther., 280, 988-1000.
17. BROSTJAN, C., ANRATHER, J., CSIZMADIA, V., NATARAJAN, G. & WINKLER, H. (1997). Glucocorticoids inhibit E-selectin expression by targeting NF-κB and not ATF/c-Jun. J. Immunol., 158, 3836-3844.
18. BROWN, K., GERSTBERGER, S., CARLSON, L., FRANZOSO, G. & SIEBENLIST, U. (1995). Control of IκB-a proteolysis by site-specific, signal-induced phosphorylation. Science, 267, 1485-1488.
19. CATO, A.C. & WADE, E. (1996). Molecular mechanisms of anti-inflammatory action of glucocorticoids. Bioessays, 18, 371-378.
20. CONNER, E.M., BRAND, S., DAVIS, J.M., LAROUX, F.S., PALOMBELLA, V.J., FUSELER, J.W., KANG, D.Y., WOLF, R.E. & GRISHAM, M.B. (1997). Proteasome inhibition attenuates nitric oxide synthase expression, VCAM-1 transcription and the development of chronic colitis. J. Pharmacol. Exp. Ther., 282, 1615-1622.
21. ELICES, M.J., OSBORN, L., TAKADA, Y., CROUSE, C., LUHOWSKYJ, S., HEMLER, M. & LOBB, R.R. (1990). VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site. Cell, 60, 577-584.
22. EPPIHIMER, M.J., RUSSELL, J., ANDERSON, D.C., WOLITZKY, B.A. & GRANGER, D.N. (1997). Endothelial cell adhesion molecule expression in gene-targeted mice. Am. J. Physiol., 273, H1903-H1908.
23. EPPIHIMER, M.J., WOLITZKY, B., ANDERSON, D.C., LABOW, M.A. & GRANGER, D.N. (1996). Heterogeneity of expression of E- and P-selectins in vivo. Circ. Res., 79, 560-569.
24. ESSANI, N.A., MCGUIRE, G.M., MANNING, A.M. & JAESCHKE, H. (1996). Endotoxin-induced activation of the nuclear transcription factor κB and expression of E-selectin messenger RNA in hepatocytes, Kupffer cells, and endothelial cells in vivo. J. Immunol., 156, 2956-2963.
25. FISHER, C.J., JR., SLOTMAN, G.J., OPAL, S.M., PRIBBLE, J.P., BONE, R.C., EMMANUEL, G., NG, D., BLOEDOW, D.C. & CATALANO, M.A. (1994). Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: a randomized, open-label, placebo-controlled multicenter trial. The IL-1RA Sepsis Syndrome Study Group. Crit. Care Med., 22, 12-21.
26. FRIES, J.W., WILLIAMS, A.J., ATKINS, R.C., NEWMAN, W., LIPSCOMB, M.F. & COLLINS, T. (1993). Expression of VCAM-1 and E-selectin in an in vivo model of endothelial activation. Am. J. Pathol., 143, 725-737.
27. GIBSON, I. (1996). Antisense approaches to the gene therapy of cancer. Cancer Metastasis Rev., 15, 287-299.
28. GUVAKOVA, M.A., YAKUBOV, L.A., VLODAVSKY, I., TONKINSON, J.L. & STEIN, C.A. (1995). Phosphorothioate oligodeoxynucleotides bind to basic fibroblast growth factor, inhibit its binding to cell surface receptors, and remove it from low affinity binding sites on extracellular matrix. J. Biol. Chem., 270, 2620-2627.
29. HANDEL, M.L. (1997). Transcription factors AP-1 and NF-κB: where steroids meet the gold standard of anti-rheumatic drugs. Inflamm. Res., 46, 282-286.
30. HANDEL, M.L., WATTS, C.K., SIVERTSEN, S., DAY, R.O. & SUTHERLAND, R.L. (1996). D-penicillamine causes free radical-dependent inactivation of activator protein-1 DNA binding. Mol. Pharmacol., 50, 501-505.
31. HAUG, C.E., COLVIN, R.B., DELMONICO, F.L., AUCHINCLOSS, H., JR., TOLKOFF RUBIN, N., PREFFER, F.I., ROTHLEIN, R., NORRIS, S., SCHARSCHMIDT, L. & COSIMI, A.B. (1993). A phase I trial of immunosuppression with anti-ICAM-1 (CD54) mAb in renal allograft recipients. Transplantation, 55, 766-772.
32. HAYWARD, R., CAMPELL, B., SHIN, Y.K., SCALIA, R. & LEFER, A.M. (1998). Recombinant soluble P-selectin glycoprotein ligand protects against myocardial ischemic reperfusion injury in cats. Cardiovasc. Res., (in press).
33. HENNINGER, D.D., PANÉS, J., EPPIHIMER, M., RUSSELL, J., GERRITSEN, M., ANDERSON, D.C. & GRANGER, D.N. (1997). Cytokine-induced VCAM-1 and ICAM-1 expression in different organs of the mouse. J. Immunol., 158, 1825-1832.
34. HORIE, Y., WOLF, R., ANDERSON, D.C. & GRANGER, D.N. (1997a). Hepatic leukostasis and hypoxic stress in adhesion molecule-deficient mice alter gut ischaemia/reperfusion. J. Clin. Invest., 99, 781-788.
35. HORIE, Y., WOLF, R., RUSSELL, J., SHANLEY, T.P. & GRANGER, D.N. (1997b). Role of Kupffer cells in gut ischaemia/reperfusion-induced hepatic microvascular dysfunction in mice. Hepatology, 26, 1499-1505.
36. KARIN, M. & SMEAL, T. (1992). Control of transcription factors by signal transduction pathways: the beginning of the end. Trends Biochem. Sci., 17, 418-422.
37. KAVANAUGH, A.F., DAVIS, L.S., NICHOLS, L.A., NORRIS, S.H., ROTHLEIN, R., SCHARSCHMIDT, L.A. & LIPSKY, P.E. (1994). Treatment of refractory rheumatoid arthritis with a monoclonal antibody to intercellular adhesion molecule 1. Arthritis Rheum., 37, 992-999.
38. KHALED, A.R., BUTFILOSKI, E.J., SOBEL, E.S. & SCHIFFENBAUER, J. (1998). Use of phosphorothioate-modified oligodeoxynucleotides to inhibit NF-κB expression and lymphocyte function. Clin. Immunol. Immunopathol., 86, 170-179.
39. KHALED, Z., BENIMEISKAYA, L., ZELTSER, R., KHAN, T., SHARMA, H.W., NARAYANAN, R. & STEIN, C.A. (1996). Multiple mechanisms may contribute to the cellular anti-adhesive effects of phosphorothioate oligodeoxynucleotides. Nucleic Acids Res., 24, 737-745.
40. KOIKE, R., MIKI, I., OTOSHI, M., TOTSUKA, T., INOUE, H., KASE, H., SAITO, I. & MIYASAKA, N. (1994). Gold sodium thiomalate down-regulates intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 expression on vascular endothelial cells. Mol. Pharmacol., 46, 599-604.
41. KOMATSU, S., FLORES, S., GERRITSEN, M.E., ANDERSON, D.C. & GRANGER, D.N. (1997). Differential up-regulation of circulating soluble and endothelial cell intercellular adhesion molecule-1 in mice. Am. J. Pathol., 151, 205-214.
42. KOPP, E. & GHOSH, S. (1994). Inhibition of NF-κB by sodium salicylate and aspirin. Science, 265, 956-959.
43. KORTHUIS, R.J., ANDERSON, D.C. & GRANGER, D.N. (1994). Role of neutrophil-endothelial cell adhesion in inflammatory disorders. J. Crit. Care, 9, 47-71.
44. KUBES, P., IBBOTSON, G., RUSSELL, J., WALLACE, J.L. & GRANGER, D.N. (1990a). Role of platelet-activating factor in ischaemia/reperfusion-induced leukocyte adherence. Am. J. Physiol., 259, G300-G305.
45. KUBES, P., KUROSE, I. & GRANGER, D.N. (1994). NO donors prevent integrin-induced leukocyte adhesion but not P-selectin-dependent rolling in postischemic venules. Am. J. Physiol., 267, H931-H937.
46. KUBES, P., SUZUKI, M. & GRANGER, D.N. (1990b). Platelet-activating factor-induced microvascular dysfunction: role of adherent leukocytes. Am. J. Physiol., 258, G158-G163.
47. KUMASAKA, T., QUINLAN, W.M., DOYLE, N.A., CONDON, T.P., SLIGH, J., TAKEI, F., BEAUDET, A., BENNETT, C.F. & DOERSCHUK, C.M. (1996). Role of the intercellular adhesion molecule-1 (ICAM-1) in endotoxin-induced pneumonia evaluated using ICAM-1 antisense oligonucleotides, anti-ICAM-1 monoclonal antibodies, and ICAM-1 mutant mice. J. Clin. Invest., 97, 2362-2369.
48. KUNKEL, E.J., JUNG, U., BULLARD, D.C., NORMAN, K.E., WOLITZKY, B.A., VESTWEBER, D., BEAUDET, A.L. & LEY, K. (1996). Absence of trauma-induced leukocyte rolling in mice deficient in both P-selectin and intercellular adhesion molecule 1. J. Exp. Med., 183, 57-65.
49. KUROSE, I., ANDERSON, D.C., MIYASAKA, M., TAMATANI, T., PAULSON, J.C., TODD, R.F., RUSCHE, J.R. & GRANGER, D.N. (1994a). Molecular determinants of reperfusion-induced leukocyte adhesion and vascular protein leakage. Circ. Res., 74, 336-343.
50. KUROSE, I., ARGENBRIGHT, L.W., WOLF, R., LIANXI, L. & GRANGER, D.N. (1997). Ischaemia/reperfusion-induced microvascular dysfunction: role of oxidants and lipid mediators. Am. J. Physiol., 272, H2976-H2982.
51. KUROSE, I., GRANGER, D.N., EVANS, D.J., JR., EVANS, D.G., GRAHAM, D.Y., MIYASAKA, M., ANDERSON, D.C., WOLF, R.E., CEPINSKAS, G. & KVIETYS, P.R. (1994b). Helicobacter pylori-induced microvascular protein leakage in rats: role of neutrophils, mast cells, and platelets. Gastroenterology, 107, 70-79.
52. KUROSE, I., POTHOULAKIS, C., LA MONT, J.T., ANDERSON, D.C., PAULSON, J.C., MIYASAKA, M., WOLF, R. & GRANGER, D.N. (1994c). Clostridium difficile toxin A-induced microvascular dysfunction. Role of histamine. J. Clin. Invest., 94, 1919-1926.
53. KUSTERER, K., BOJUNGA, J., ENGHOFER, M., HEIDENTHAL, E., USADEL, K.H., KOLB, H. & MARTIN, S. (1998). Soluble ICAM-1 reduces leukocyte adhesion to vascular endothelium in ischaemia-reperfusion injury in mice. Am. J. Physiol., 275, G377-G380.
54. LE MAUFF, B., HOURMANT, M., ROUGIER, J.P., HIRN, M., DANTAL, J., BAATARD, R., CANTAROVICH, D., JACQUES, Y. & SOULILLOU, J.P. (1991). Effect of anti-LFA1 (CD11a) monoclonal antibodies in acute rejection in human kidney transplantation. Transplantation, 52, 291-296.
55. LEE, C.H., CHEN, H.H., HOKE, G., JONG, J.S., WHITE, L. & KANG, Y.H. (1995). Antisense gene suppression against human ICAM-1, ELAM-1, and VCAM-1 in cultured human umbilical vein endothelial cells. Shock, 4, 1-10.
56. LIAO, L. & GRANGER, D.N. (1996). Role of mast cells in oxidized low-density lipoprotein-induced microvascular dysfunction. Am. J. Physiol., 271, H1795-H1800.
57. LO, S.K., JANAKIDEVI, K., LAI, L. & MALIK, A.B. (1993). Hydrogen peroxide-induced increase in endothelial adhesiveness is dependent on ICAM-1 activation. Am. J. Physiol., 264, L406-L412.
58. MARLIN, S.D. & SPRINGER, T.A. (1987). Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function-associated antigen (LFA-1). Cell, 51, 813-819.
59. MAY, M.J. & GHOSH, S. (1998). Signal transduction through NF-κB. Immunol. Today, 19, 80-88.
60. MORISHITA, R., HIGAKI, J., TOMITA, N. & OGIHARA, T. (1998). Application of transcription factor 'decoy' strategy as means of gene therapy and study of gene expression in cardiovascular disease. Circ. Res., 82, 1023-1028.
61. MORISHITA, R., SUGIMOTO, T., AOKI, M., KIDA, I., TOMITA, N., MORIGUCHI, A., MAEDA, K., SAWA, Y., KANEDA, Y., HIGAKI, J. & OGIHARA, T. (1997). In vivo transfection of cis element 'decoy' against nuclear factor-kappaB binding site prevents myocardial infarction. Nat. Med., 3, 894-899.
62. MULLER, W.A., WEIGL, S.A., DENG, X. & PHILLIPS, D.M. (1993). PECAM-1 is required for transendothelial migration of leukocytes. J. Exp. Med., 178, 449-460.
63. MULLIGAN, M.S., JONES, M.L., BOLANOWSKI, M.A., BAGANOFF, M.P., DEPPELER, C.L., MEYERS, D.M., RYAN, U.S. & WARD, P.A. (1993). Inhibition of lung inflammatory reactions in rats by an anti-human IL-8 antibody. J. Immunol., 150, 5585-5595.
64. NARAYANAN, R., HIGGINS, K.A., PEREZ, J.R., COLEMAN, T.A. & ROSEN, C.A. (1993). Evidence for differential functions of the p50 and p65 subunits of NF-kappa B with a cell adhesion model. Mol. Cell. Biol., 13, 3802-3810.
65. NEURATH, M.F., PETTERSSON, S., MEYER ZUM BÜSCHENFELDE, K.H. & STROBER, W. (1996). Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit NF-κB abrogates established experimental colitis in mice. Nat. Med., 2, 998-1004.
66. PAN, J., XIA, L. & MCEVER, R.P. (1998a). Comparison of promoters for the murine and human P-selectin genes suggests species-specific and conserved mechanisms for transcriptional regulation in endothelial cells. J. Biol. Chem, 273, 10058-10067.
67. PAN, J., XIA, L., YAO, L. & MCEVER, R.P. (1998b). Tumour necrosis factor-alpha- or lipopolysaccharide-induced expression of the murine P-selectin gene in endothelial cells involves novel kappaB sites and a variant activating transcription factor/camp response element. J. Biol. Chem., 273, 10068-10077.
68. PANÉS, J. & GRANGER, D.N. (1998). Leukocyte-endothelial cell interactions: molecular mechanisms and implications in gastrointestinal disease. Gastroenterology, 114, 1066-1090.
69. PANÉS, J., PERRY, M.A., ANDERSON, D.C., MANNING, A., LEONE, B., CEPINSKAS, G., ROSENBLOOM, C.L., MIYASAKA, M., KVIETYS, P.R. & GRANGER, D.N. (1995). Regional differences in constitutive and induced ICAM-1 expression in vivo. Am. J. Physiol., 269, H1955-H1964.
70. PIERCE, J.W., READ, M.A., DING, H., LUSCINSKAS, F.W. & COLLINS, T. (1996). Salicylates inhibit IκB-a phosphorylation, endothelial-leukocyte adhesion molecule expression, and neutrophil transmigration. J. Immunol., 156, 3961-3969.
71. RAY, A. & PREFONTAINE, K.E. (1994). Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor. Proc. Natl. Acad. Sci. U.S.A., 91, 752-756.
72. READ, M.A., NEISH, A.S., LUSCINSKAS, F.W., PALOMBELLA, V.J., MANIATIS, T. & COLLINS, T. (1995). The proteasome pathway is required for cytokine-induced endothelial-leukocyte adhesion molecule expression. Immunity, 2, 493-506.
73. ROEBUCK, K.A., RAHMAN, A., LAKSHMINARAYANAN, V., JANAKIDEVI, K. & MALIK, A.B. (1995). H2O2 and tumour necrosis factor-alpha activate intercellular adhesion molecule 1 (ICAM-1) gene transcription through distinct cis-regulatory elements within the ICAM-1 promoter. J. Biol. Chem., 270, 18966-18974.
74. ROMER, L.H., MCLEAN, N.V., YAN, H.C., DAISE, M., SUN, J. & DE LISSER, H.M. (1995). IFN-g and TNF-a induce redistribution of PECAM-1 (CD31) on human endothelial cells. J. Immunol., 154, 6582- 6592.
75. SAKURAI, H., SHIGEMORI, N., HISADA, Y., ISHIZUKA, T., KAWASHIMA, K. & SUGITA, T. (1997). Suppression of NF-κB and AP-1 activation by glucocorticoids in experimental glomerulonephritis in rats: molecular mechanisms of anti-nephritic action. Biochim. Biophys. Acta., 1362, 252-262.
76. SAWA, Y., MORISHITA, R., SUZUKI, K., KAGISAKI, K., KANEDA, Y., MAEDA, K., KADOBA, K. & MATSUDA, H. (1997). A novel strategy for myocardial protection using in vivo transfection of cis element 'decoy' against NF-κB binding site: evidence for a role of NF-κB in ischaemia-reperfusion injury. Circulation, 96, H280-H285.
77. SCHEINMAN, R.I., GUALBERTO, A., JEWELL, C.M., CIDLOWSKI, J.A. & BALDWIN, A.S., J.R. (1995). Characterization of mechanisms involved in transrepression of NF-κB by activated glucocorticoid receptors. Mol. Cell. Biol., 15, 943-953.
78. SHA, W.C., LIOU, H.C., TUOMANEN, E.I. & BALTIMORE, D. (1995). Targeted disruption of the p50 subunit of NF-kappa B leads to multifocal defects in immune responses. Cell, 80, 321-330.
79. SHARMA, H.W. & NARAYANAN, R. (1995). The therapeutic potential of antisense oligonucleotides. Bioessays, 17, 1055-1063.
80. SHELLEY, C.S., DA SILVA, N., GEORGAKIS, A., CHOMIENNE, C. & ARNAOUT, M.A. (1998). Mapping of the human CD11c (ITGAX) and CD11d (ITGAD) genes demonstrates that they are arranged in tandem separated by no more than 11.5 kb. Genomics, 49, 334-336.
81. SOKOLOSKI, J.A., SARTORELLI, A.C., ROSEN, C.A. & NARAYANAN, R. (1993). Antisense oligonucleotides to the p65 subunit of NF-κB block CD11b expression and alter adhesion properties of differentiated HL-60 granulocytes. Blood. 82, 625-632.
82. STEPKOWSKI, S.M., TU, Y., CONDON, T.P. & BENNETT, C.F. (1994). Blocking of heart allograft rejection by intercellular adhesion molecule-1 antisense oligonucleotides alone or in combination with other immunosuppressive modalities. J. Immunol., 153, 5336-5346.
83. TAILOR, A., DAS, A.M., GETTING, S.J., FLOWER, R.J. & PERRETTI, M. (1997). Subacute treatment of rats with dexamethasone reduces ICAM-1 levels on circulating monocytes. Biochem. Biophys. Res. Commun., 231, 675-678.
84. TAKADA, M., NADEAU, K.C., SHAW, G.D. & TILNEY, N.L. (1997). Prevention of late renal changes after initial ischaemia/reperfusion injury by blocking early selectin binding. Transplantation, 64, 1520-1525.
85. TAKEUCHI, M. & BAICHWAL, V.R. (1995). Induction of the gene encoding mucosal vascular address in cell adhesion molecule 1 by tumour necrosis factor alpha is mediated by NF-κB proteins. Proc. Natl. Acad. Sci. U.S.A., 92, 3561-3565.
86. TARGAN, S.R., HANAUER, S.B., VAN DEVENTER, S.J., MAYER, L., PRESENT, D.H., BRAAKMAN, T., DEWOODY, K.L., SCHAIBLE, T.F. & RUTGEERTS, P.J. (1997). A short-term study of chimeric monoclonal antibody cA2 to tumour necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group. N. Engl. J. Med., 337, 1029-1035.
87. TEDDER, T.F., STEEBER, D.A., CHEN, A. & ENGEL, P. (1995a). The selectins: vascular adhesion molecules. FASEB J., 9, 866-873.
88. TEDDER, T.F., STEEBER, D.A. & PIZCUETA, P. (1995b). L-selectin-deficient mice have impaired leukocyte recruitment into inflammatory sites. J. Exp. Med., 181, 2259-2264.
89. TESSIER, P.A., CATTARUZZI, P. & MCCOLL, S.R. (1996). Inhibition of lymphocyte adhesion to cytokine-activated synovial fibroblasts by glucocorticoids involves the attenuation of vascular cell adhesion molecule 1 and intercellular adhesion molecule 1 gene expression. Arthritis Rheum., 39, 226-234.
90. TSUZUKI, Y., MIURA, S., SUEMATSU, M., KUROSE, I., SHIGEMATSU, T., KIMURA, H., HIGUCHI, H., SERIZAWA, H., YAGITA, H., OKUMURA, K. & ISHII, H. (1996). a4 integrin plays a critical role in early stages of T lymphocyte migration in Peyer's patches of rats. Intl. Immunol., 8, 287-295.
91. VAN DIJKEN, P.J., GHAYUR, T., MAUCH, P., DOWN, J., BURAKOFF, S.J. & FERRARA, J.L. (1990). Evidence that anti-LFA-1 in vivo improves engraftment and survival alter allogeneic bone marrow transplantation. Transplantation, 49, 882-886.
92. WAKELIN, M.W., SANZ, M.J., DEWAR, A., ALBELDA, S.M., LARKIN, S.W., BOUGHTON-SMITH, N., WILLIAMS, T.J. & NOURSHARGH, S. (1996). An anti-platelet-endothelial cell adhesion molecule-1 antibody inhibits leukocyte extravasation from mesenteric microvessels in vivo by blocking the passage through the basement membrane. J. Exp. Med., 184, 229-239.
93. WANG, C.Y., MAYO, M.W. & BALDWLN, A.S., JR. (1996). TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-κB. Science, 274, 784-787.
94. WEYRICH, A.S., MA, X.Y., LEFER, D.J., ALBERTINE, K.H. & LEFER, A.M. (1993). In vivo neutralization of P-selectin protects feline heart and endothelium in myocardial ischaemia and reperfusion injury. J. Clin. Invest., 91, 2620-2629.
95. WILLIAMS, D.H, JEFFERY, L.J. & MURRAY, E.J. (1992). Aurothio-Glucose inhibits induced NF-κ?B and AP-1 activity by acting as an IL-1 functional antagonist. Biochim. Biophys. Acta., 1180, 9-14.
96. XU, H., GONZALO, J.A., ST-PIERRE, Y., WILLIAMS, I.R., KUPPER, T.S., COTRAN, R.S., SPRINGER, T.A. & GUTIERREZ-RAMOS, J.C. (1994). Leukocytosis and resistance to septic shock in intercellular adhesion molecule 1-deficient mice. J. Exp. Med., 180, 95-109.
97. YACYSHYN, B.R., BOWEN-YACYSHYN, M.B., JEWELL, L., TAMI, J.A., BENNETT, C.F., KISNER, D.L. & SHANAHAN, W.R. (1998). A placebo-controlled trial of ICAM-1 antisense oligonucleotide in the treatment of Crohn's disease. Gastroenterology, 14, 1133-1142.
98. YAKUBOV, L.A., DEEVA, E.A., ZARYTOVA, V.F., IVANOVA, E.M., RYTE, A.S., YURCHENKO, L.V. & VLASSOV, V.V. (1989). Mechanism of oligonucleotide uptake by cells: involvement of specific receptors? Proc. Natl. Acad. Sci. U.S.A., 86, 6454-6458.
99. YANG, J.P., MERIN, J.P., NAKANO, T., KATO, T., KITADE, Y. & OKAMOTO, T. (1995). Inhibition of the DNA-binding activity of NF-κB by gold compounds in vitro. FEBS Lett., 361, 89-96.
100. YAO, L., PAN, J., SETIADI, H., PATEL, K.D. & MCEVER, R.P. (1996). Interleukin 4 or oncostatin M induces a prolonged increase in P-selectin mRNA and protein in human endothelial cells. J. Exp. Med., 184, 81-92.
101. ZIMMERMAN, B.J., GUILLORY, D.J., GRISHAM, M.B., GAGINELLA, T.S. & GRANGER, D.N. (1990). Role of leukotriene B4 in granulocyte infiltration into the postischemic feline intestine. Gastroenterology, 99, 1358-1363.
102. ZIMMERMAN, B.J., HOLT, J.W., PAULSON, J.C., ANDERSON, D.C., MIYASAKA, M., TAMATANI, T., TODD, R.F.R., RUSCHE, J.R. & GRANGER, D.N. (1994a). Molecular determinants of lipid mediator-induced leukocyte adherence and emigration in rat mesenteric venules. Am. J. Physiol., 266, H847-H853.
103. ZIMMERMAN, B.J., PAULSON, J.C., ARRHENIUS, T.S., GAETA, F.C.A. & GRANGER, D.N. (1994b). Thrombin receptor peptide-mediated leukocyte rolling in rat mesenteric venules: role of P-selectin and sialyl Lewis X. Am. J. Physiol., 267, H1049-H1053.